Pseudocholinesterase enzyme deficiency: a case series and review of the literature
Open Access
- 4 December 2009
- journal article
- review article
- Published by Springer Nature in Cases Journal
- Vol. 2 (1) , 1-5
Abstract
Pseudocholinesterase (butyrylcholinesterase) is a drug metabolizing enzyme responsible for hydrolysis of the muscle relaxant drugs succinylcholine and mivacurium. Deficiency from any cause can lead to prolonged apnoea and paralysis following administration of succinylcholine and mivacurium. Within the last two years we have had four patients who have had prolonged apnea following the administration of mivacurium. It was understood that one was congenital and the other three due to various reasons had enzyme-deficiencies. In all four of the patients, the prolonged blocks deteriorated. Prolonged blocks may be encountered due to mivacurium use. The diagnosis of pseudocholinesterase enzyme deficiency can be given after a careful clinic supervision and peripheral nerve stimulator monitoring. A decrease in the activity of pseudocholinesterase enzyme and improvement in neuromuscular function will help verifying our diagnosis. Instead of pharmacological applications that may further complicate the situation, what should be done in such patients is to wait until the block-effect goes down by the help of sedation and mechanical ventilation.Keywords
This publication has 19 references indexed in Scilit:
- Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activityBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Screening Patients with Prolonged Neuromuscular Blockade After Succinylcholine and MivacuriumAnesthesia & Analgesia, 2002
- Cholinesterase Its significance in anaesthetic practiceAnaesthesia, 1997
- Plasma CholinesteraseAnesthesia & Analgesia, 1993
- Prolonged Neuromuscular Block from Mivacurium in Two Patients with Cholinesterase DeficiencyAnesthesia & Analgesia, 1993
- MivacuriumDrugs, 1993
- Mivacurium‐induced neuromuscular blockade in patients with atypical plasma cholinesteraseActa Anaesthesiologica Scandinavica, 1993
- Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patientsActa Anaesthesiologica Scandinavica, 1992
- MIVACURIUM INDUCED NEURCMUSCULAR BLOCKADE (NMB) IN PATIENTS HETEROZYGOUS FOR THE ATYPICAL GENE FOR PLASMA CHOLINESTERASEAnesthesiology, 1989
- Half–life of plasma cholinesteraseActa Anaesthesiologica Scandinavica, 1988